$NBY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NovaBay Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NovaBay Pharmaceuticals, Inc.. Get notifications about new insider transactions in NovaBay Pharmaceuticals, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 09 2014 | NBY | NovaBay Pharmaceut ... | Tufts Robert R. | Director | Option Exercise | A | 1.29 | 15,000 | 19,350 | 160,885 | |
Jan 09 2014 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Option Exercise | A | 1.29 | 15,000 | 19,350 | 295,807 | |
Jan 09 2014 | NBY | NovaBay Pharmaceut ... | Maderis Gail J | Director | Option Exercise | A | 1.29 | 15,000 | 19,350 | 206,464 | |
Jan 09 2014 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Option Exercise | A | 1.29 | 15,000 | 19,350 | 237,510 | |
Jan 09 2014 | NBY | NovaBay Pharmaceut ... | Dailley Anthony | Director | Option Exercise | A | 1.29 | 15,000 | 19,350 | 203,217 | |
Jan 09 2014 | NBY | NovaBay Pharmaceut ... | Cashion Charles | Director | Option Exercise | A | 1.29 | 15,000 | 19,350 | 276,459 | |
Dec 04 2013 | NBY | NovaBay Pharmaceut ... | China Pioneer Pharma Holdings ... | 10% Owner | Option Exercise | H | 1.50 | 1,200,000 | 1,800,000 | 0 | |
Dec 04 2013 | NBY | NovaBay Pharmaceut ... | China Pioneer Pharma Holdings ... | 10% Owner | Option Exercise | H | 1.50 | 800,000 | 1,200,000 | 0 | |
Dec 04 2013 | NBY | NovaBay Pharmaceut ... | China Pioneer Pharma Holdings ... | 10% Owner | Buy | P | 1.14 | 5,000,000 | 5,700,000 | 7,005,656 | 2 M to 7 M (+249.29 %) |
Dec 04 2013 | NBY | NovaBay Pharmaceut ... | Pioneer Pharma (Singapore) Pte ... | 10% Owner | Option Exercise | H | 1.50 | 1,200,000 | 1,800,000 | 0 | |
Dec 04 2013 | NBY | NovaBay Pharmaceut ... | Pioneer Pharma (Singapore) Pte ... | 10% Owner | Option Exercise | H | 1.50 | 800,000 | 1,200,000 | 0 | |
Dec 04 2013 | NBY | NovaBay Pharmaceut ... | Pioneer Pharma (Singapore) Pte ... | 10% Owner | Buy | P | 1.14 | 5,000,000 | 5,700,000 | 7,005,656 | 2 M to 7 M (+249.29 %) |
Dec 04 2013 | NBY | NovaBay Pharmaceut ... | Pioneer Pharma (Hong Kong) Co ... | 10% Owner | Option Exercise | H | 1.50 | 1,200,000 | 1,800,000 | 0 | |
Dec 04 2013 | NBY | NovaBay Pharmaceut ... | Pioneer Pharma (Hong Kong) Co ... | 10% Owner | Option Exercise | H | 1.50 | 800,000 | 1,200,000 | 0 | |
Dec 04 2013 | NBY | NovaBay Pharmaceut ... | Pioneer Pharma (Hong Kong) Co ... | 10% Owner | Buy | P | 1.14 | 5,000,000 | 5,700,000 | 7,005,656 | 2 M to 7 M (+249.29 %) |
Dec 02 2013 | NBY | NovaBay Pharmaceut ... | Pioneer Pharma (Hong Kong) Co ... | 10% Owner | Buy | J | 0.00 | 3,913 | 0 | 2,005,656 | 2 M to 2 M (+0.20 %) |
Dec 02 2013 | NBY | NovaBay Pharmaceut ... | China Pioneer Pharma Holdings ... | 10% Owner | Buy | P | 1.02 | 108,156 | 110,319 | 108,156 | 0 to 108.2 K |
Dec 02 2013 | NBY | NovaBay Pharmaceut ... | China Pioneer Pharma Holdings ... | 10% Owner | Buy | J | 0.00 | 3,913 | 0 | 2,005,656 | 2 M to 2 M (+0.20 %) |
Dec 02 2013 | NBY | NovaBay Pharmaceut ... | Pioneer Pharma (Singapore) Pte ... | 10% Owner | Buy | J | 0.00 | 3,913 | 0 | 2,005,656 | 2 M to 2 M (+0.20 %) |
Dec 02 2013 | NBY | NovaBay Pharmaceut ... | Pioneer Pharma (Singapore) Pte ... | 10% Owner | Buy | J | 0.00 | 1,743 | 0 | 2,001,743 | 2 M to 2 M (+0.09 %) |
Dec 02 2013 | NBY | NovaBay Pharmaceut ... | Li Xinzhou | 10% Owner | Buy | J | 0.00 | 1,743 | 0 | 2,001,743 | 2 M to 2 M (+0.09 %) |
Dec 02 2013 | NBY | NovaBay Pharmaceut ... | Li Xinzhou | 10% Owner | Sell | S | 1.87 | 120,000 | 224,988 | 0 | 120 K to 0 (-100.00 %) |
Oct 29 2013 | NBY | NovaBay Pharmaceut ... | PAULSON THOMAS J | CFO | Payment of Exercise | F | 1.75 | 3,645 | 6,379 | 63,855 | 67.5 K to 63.9 K (-5.40 %) |
Oct 02 2013 | NBY | NovaBay Pharmaceut ... | Bley Keith R | SVP Product Develop ... | Option Exercise | A | 1.71 | 51,000 | 87,210 | 201,000 | |
Oct 29 2013 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Payment of Exercise | F | 1.75 | 4,557 | 7,975 | 100,195 | 104.8 K to 100.2 K (-4.35 %) |
Oct 02 2013 | NBY | NovaBay Pharmaceut ... | WU ROY J | SVP Bus & Corp Deve ... | Option Exercise | A | 1.71 | 62,000 | 106,020 | 406,902 | |
Oct 02 2013 | NBY | NovaBay Pharmaceut ... | Stroman David W. | SVP, Ophthalmic Pro ... | Option Exercise | A | 1.71 | 62,000 | 106,020 | 319,823 | |
Oct 02 2013 | NBY | NovaBay Pharmaceut ... | PAULSON THOMAS J | CFO | Option Exercise | A | 1.71 | 110,000 | 188,100 | 689,809 | |
Oct 02 2013 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Option Exercise | A | 1.71 | 150,000 | 256,500 | 914,852 | |
Mar 06 2013 | NBY | NovaBay Pharmaceut ... | Bley Keith R | SVP Product Develop ... | Option Exercise | A | 1.15 | 150,000 | 172,500 | 150,000 | |
Feb 01 2013 | NBY | NovaBay Pharmaceut ... | Wicks Tony D.S. | Director | Option Exercise | A | 1.29 | 19,603 | 25,288 | 256,149 | |
Feb 01 2013 | NBY | NovaBay Pharmaceut ... | Maderis Gail J | Director | Option Exercise | A | 1.29 | 39,205 | 50,574 | 191,464 | |
Feb 01 2013 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Option Exercise | A | 1.29 | 39,205 | 50,574 | 280,807 | |
Feb 01 2013 | NBY | NovaBay Pharmaceut ... | Cashion Charles | Director | Option Exercise | A | 1.29 | 19,603 | 25,288 | 261,459 | |
Jan 15 2013 | NBY | NovaBay Pharmaceut ... | Cashion Charles | Director | Option Exercise | A | 1.13 | 15,000 | 16,950 | 241,856 | |
Jan 15 2013 | NBY | NovaBay Pharmaceut ... | Dailley Anthony | Director | Option Exercise | A | 1.13 | 15,000 | 16,950 | 188,217 | |
Jan 15 2013 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Option Exercise | A | 1.13 | 15,000 | 16,950 | 222,510 | |
Jan 15 2013 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Option Exercise | A | 1.13 | 15,000 | 16,950 | 241,602 | |
Jan 15 2013 | NBY | NovaBay Pharmaceut ... | Maderis Gail J | Director | Option Exercise | A | 1.13 | 15,000 | 16,950 | 152,259 | |
Jan 15 2013 | NBY | NovaBay Pharmaceut ... | Wicks Tony D.S. | Director | Option Exercise | A | 1.13 | 15,000 | 16,950 | 236,546 | |
Jan 15 2013 | NBY | NovaBay Pharmaceut ... | Tufts Robert R. | Director | Option Exercise | A | 1.13 | 15,000 | 16,950 | 145,885 | |
Jan 14 2013 | NBY | NovaBay Pharmaceut ... | WU ROY J | SVP Bus & Corp Deve ... | Option Exercise | A | 1.13 | 25,000 | 28,250 | 344,902 | |
Jan 14 2013 | NBY | NovaBay Pharmaceut ... | Stroman David W. | SVP, Ophthalmic Pro ... | Option Exercise | A | 1.13 | 25,000 | 28,250 | 257,823 | |
Jan 14 2013 | NBY | NovaBay Pharmaceut ... | PAULSON THOMAS J | CFO | Option Exercise | A | 1.13 | 25,000 | 28,250 | 579,809 | |
Jan 14 2013 | NBY | NovaBay Pharmaceut ... | Khosrovi Behzad | SVP Product Develop ... | Option Exercise | A | 1.13 | 25,000 | 28,250 | 536,283 | |
Jan 14 2013 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Option Exercise | A | 1.13 | 85,000 | 96,050 | 764,852 | |
Jan 03 2013 | NBY | NovaBay Pharmaceut ... | Li Xinzhou | 10% Owner | Buy | P | 1.20 | 120,000 | 144,000 | 2,120,000 | 2 M to 2.1 M (+6.00 %) |
Jan 02 2013 | NBY | NovaBay Pharmaceut ... | Li Xinzhou | 10% Owner | Option Exercise | P | 1.50 | 1,200,000 | 1,800,000 | 2,000,000 | |
Jan 02 2013 | NBY | NovaBay Pharmaceut ... | Li Xinzhou | 10% Owner | Buy | P | 1.25 | 1,200,000 | 1,500,000 | 2,000,000 | 800 K to 2 M (+150.00 %) |
Jan 02 2013 | NBY | NovaBay Pharmaceut ... | Li Xinzhou | 10% Owner | Option Exercise | P | 1.50 | 800,000 | 1,200,000 | 800,000 | |
Jan 02 2013 | NBY | NovaBay Pharmaceut ... | Li Xinzhou | 10% Owner | Buy | P | 1.25 | 800,000 | 1,000,000 | 800,000 | 0 to 800 K |
Dec 10 2012 | NBY | NovaBay Pharmaceut ... | Stroman David W. | SVP, Ophthalmic Pro ... | Option Exercise | P | 1.50 | 7,500 | 11,250 | 7,500 | |
Dec 10 2012 | NBY | NovaBay Pharmaceut ... | Stroman David W. | SVP, Ophthalmic Pro ... | Buy | P | 1.24 | 10,000 | 12,400 | 22,000 | 12 K to 22 K (+83.33 %) |
Dec 10 2012 | NBY | NovaBay Pharmaceut ... | PAULSON THOMAS J | CFO | Option Exercise | P | 1.50 | 7,500 | 11,250 | 7,500 | |
Dec 10 2012 | NBY | NovaBay Pharmaceut ... | PAULSON THOMAS J | CFO | Buy | P | 1.24 | 10,000 | 12,400 | 63,855 | 53.9 K to 63.9 K (+18.57 %) |
Dec 10 2012 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Option Exercise | P | 1.50 | 15,000 | 22,500 | 15,000 | |
Dec 10 2012 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 1.24 | 20,000 | 24,800 | 100,195 | 80.2 K to 100.2 K (+24.94 %) |
Dec 04 2012 | NBY | NovaBay Pharmaceut ... | PAULSON THOMAS J | CFO | Payment of Exercise | F | 1.31 | 3,645 | 4,775 | 53,855 | 57.5 K to 53.9 K (-6.34 %) |
Dec 04 2012 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Payment of Exercise | F | 1.31 | 4,557 | 5,970 | 80,195 | 84.8 K to 80.2 K (-5.38 %) |
Nov 20 2012 | NBY | NovaBay Pharmaceut ... | NAQU AREA PIONEER PHARMA CO., ... | 10% Owner | Option Exercise | P | 1.50 | 1,200,000 | 1,800,000 | 2,000,000 | |
Nov 20 2012 | NBY | NovaBay Pharmaceut ... | NAQU AREA PIONEER PHARMA CO., ... | 10% Owner | Buy | P | 1.25 | 1,200,000 | 1,500,000 | 2,000,000 | 800 K to 2 M (+150.00 %) |
Nov 05 2012 | NBY | NovaBay Pharmaceut ... | Pioneer Pharma (Singapore) Pte ... | 10% Owner | Option Exercise | P | 1.50 | 1,200,000 | 1,800,000 | 2,000,000 | |
Nov 05 2012 | NBY | NovaBay Pharmaceut ... | Pioneer Pharma (Singapore) Pte ... | 10% Owner | Buy | P | 1.25 | 1,200,000 | 1,500,000 | 2,000,000 | 800 K to 2 M (+150.00 %) |
Nov 01 2012 | NBY | NovaBay Pharmaceut ... | Tufts Robert R. | Director | Option Exercise | M | 0.56 | 28,500 | 15,960 | 0 | |
Nov 01 2012 | NBY | NovaBay Pharmaceut ... | Tufts Robert R. | Director | Buy | M | 0.56 | 28,500 | 15,960 | 348,408 | 319.9 K to 348.4 K (+8.91 %) |
Oct 12 2012 | NBY | NovaBay Pharmaceut ... | WU ROY J | SVP Bus & Corp Deve ... | Option Exercise | A | 1.29 | 25,000 | 32,250 | 319,902 | |
Oct 12 2012 | NBY | NovaBay Pharmaceut ... | Stroman David W. | SVP, Ophthalmic Pro ... | Option Exercise | A | 1.29 | 25,000 | 32,250 | 232,823 | |
Oct 12 2012 | NBY | NovaBay Pharmaceut ... | Khosrovi Behzad | SVP Product Develop ... | Option Exercise | A | 1.29 | 25,000 | 32,250 | 511,283 | |
Oct 12 2012 | NBY | NovaBay Pharmaceut ... | PAULSON THOMAS J | CFO | Option Exercise | A | 1.29 | 25,000 | 32,250 | 554,809 | |
Oct 12 2012 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Option Exercise | A | 1.29 | 65,000 | 83,850 | 679,852 | |
May 31 2012 | NBY | NovaBay Pharmaceut ... | PAULSON THOMAS J | CFO | Buy | P | 0.94 | 10,000 | 9,364 | 17,500 | 7.5 K to 17.5 K (+133.33 %) |
May 29 2012 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 0.99 | 3,500 | 3,465 | 28,752 | 25.3 K to 28.8 K (+13.86 %) |
May 30 2012 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 0.96 | 2,000 | 1,920 | 34,752 | 32.8 K to 34.8 K (+6.11 %) |
May 30 2012 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 0.96 | 4,000 | 3,836 | 32,752 | 28.8 K to 32.8 K (+13.91 %) |
Feb 23 2012 | NBY | NovaBay Pharmaceut ... | WU ROY J | SVP Bus & Corp Deve ... | Option Exercise | A | 1.44 | 48,902 | 70,419 | 294,902 | |
Feb 23 2012 | NBY | NovaBay Pharmaceut ... | Stroman David W. | SVP, Ophthalmic Pro ... | Option Exercise | A | 1.44 | 7,823 | 11,265 | 207,823 | |
Feb 23 2012 | NBY | NovaBay Pharmaceut ... | Khosrovi Behzad | SVP Product Develop ... | Option Exercise | A | 1.44 | 52,083 | 75,000 | 486,283 | |
Feb 23 2012 | NBY | NovaBay Pharmaceut ... | PAULSON THOMAS J | CFO | Option Exercise | A | 1.44 | 54,709 | 78,781 | 529,809 | |
Feb 23 2012 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Option Exercise | A | 1.44 | 96,652 | 139,179 | 614,852 | |
Jan 05 2012 | NBY | NovaBay Pharmaceut ... | Wicks Tony D.S. | Director | Option Exercise | A | 1.33 | 66,230 | 88,086 | 66,230 | |
Jan 05 2012 | NBY | NovaBay Pharmaceut ... | Tufts Robert R. | Director | Option Exercise | A | 1.33 | 67,510 | 89,788 | 67,510 | |
Jan 05 2012 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Option Exercise | A | 1.33 | 79,037 | 105,119 | 79,037 | |
Jan 05 2012 | NBY | NovaBay Pharmaceut ... | Maderis Gail J | Director | Option Exercise | A | 1.33 | 67,510 | 89,788 | 67,510 | |
Jan 05 2012 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Option Exercise | X | 0.20 | 30,000 | 6,000 | 30,000 | |
Jan 05 2012 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Buy | X | 0.20 | 30,000 | 6,000 | 45,137 | 15.1 K to 45.1 K (+198.19 %) |
Jan 05 2012 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Option Exercise | A | 1.33 | 67,510 | 89,788 | 67,510 | |
Jan 05 2012 | NBY | NovaBay Pharmaceut ... | Dailley Anthony | Director | Option Exercise | A | 1.33 | 66,230 | 88,086 | 66,230 | |
Jan 05 2012 | NBY | NovaBay Pharmaceut ... | Cashion Charles | Director | Option Exercise | A | 1.33 | 68,791 | 91,492 | 68,791 | |
Nov 01 2011 | NBY | NovaBay Pharmaceut ... | WU ROY J | SVP Bus & Corp Deve ... | Option Exercise | A | 1.09 | 56,000 | 61,040 | 246,000 | |
Nov 01 2011 | NBY | NovaBay Pharmaceut ... | Anderson Mark Brian | CSO | Option Exercise | A | 1.09 | 56,000 | 61,040 | 242,000 | |
Nov 01 2011 | NBY | NovaBay Pharmaceut ... | Khosrovi Behzad | SVP Product Develop ... | Option Exercise | A | 1.09 | 70,000 | 76,300 | 434,200 | |
Nov 01 2011 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Option Exercise | A | 1.09 | 70,000 | 76,300 | 518,200 | |
Nov 01 2011 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Grant | A | 1.09 | 50,000 | 54,500 | 202,673 | 152.7 K to 202.7 K (+32.75 %) |
Nov 01 2011 | NBY | NovaBay Pharmaceut ... | PAULSON THOMAS J | CFO | Option Exercise | A | 1.09 | 56,000 | 61,040 | 435,100 | |
Nov 01 2011 | NBY | NovaBay Pharmaceut ... | PAULSON THOMAS J | CFO | Grant | A | 1.09 | 40,000 | 43,600 | 40,000 | 0 to 40 K |
Oct 06 2011 | NBY | NovaBay Pharmaceut ... | Stroman David W. | SVP, Ophthalmic Pro ... | Option Exercise | A | 0.86 | 200,000 | 172,000 | 0 | |
Oct 03 2011 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Grant | A | 0.90 | 152,673 | 137,406 | 177,925 | 25.3 K to 177.9 K (+604.60 %) |
Sep 13 2011 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Buy | P | 0.84 | 3,000 | 2,520 | 15,137 | 12.1 K to 15.1 K (+24.72 %) |
Aug 29 2011 | NBY | NovaBay Pharmaceut ... | PAULSON THOMAS J | CFO | Buy | P | 0.86 | 3,000 | 2,580 | 7,500 | 4.5 K to 7.5 K (+66.67 %) |
Aug 29 2011 | NBY | NovaBay Pharmaceut ... | PAULSON THOMAS J | CFO | Buy | P | 0.86 | 500 | 430 | 4,500 | 4 K to 4.5 K (+12.50 %) |
Aug 16 2011 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 0.85 | 10,000 | 8,500 | 25,252 | 15.3 K to 25.3 K (+65.57 %) |
Aug 16 2011 | NBY | NovaBay Pharmaceut ... | Tufts Robert R. | Director | Buy | P | 0.85 | 5,000 | 4,242 | 319,908 | 314.9 K to 319.9 K (+1.59 %) |
May 31 2011 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 1.59 | 500 | 797 | 15,252 | 14.8 K to 15.3 K (+3.39 %) |
May 31 2011 | NBY | NovaBay Pharmaceut ... | Khosrovi Behzad | VP Research and Dev ... | Buy | P | 1.65 | 700 | 1,155 | 136,000 | 135.3 K to 136 K (+0.52 %) |
May 31 2011 | NBY | NovaBay Pharmaceut ... | Khosrovi Behzad | VP Research and Dev ... | Buy | P | 1.63 | 300 | 489 | 135,300 | 135 K to 135.3 K (+0.22 %) |
May 27 2011 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Buy | P | 1.65 | 1,700 | 2,805 | 6,700 | 5 K to 6.7 K (+34.00 %) |
May 27 2011 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Buy | P | 1.64 | 100 | 164 | 5,000 | 4.9 K to 5 K (+2.04 %) |
May 27 2011 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Buy | P | 1.63 | 100 | 163 | 4,900 | 4.8 K to 4.9 K (+2.08 %) |
May 27 2011 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Buy | P | 1.64 | 100 | 164 | 4,800 | 4.7 K to 4.8 K (+2.13 %) |
May 27 2011 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Buy | P | 1.65 | 500 | 825 | 4,700 | 4.2 K to 4.7 K (+11.90 %) |
May 27 2011 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Buy | P | 1.63 | 100 | 163 | 4,200 | 4.1 K to 4.2 K (+2.44 %) |
May 27 2011 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Buy | P | 1.64 | 100 | 164 | 4,100 | 4 K to 4.1 K (+2.50 %) |
May 27 2011 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Buy | P | 1.65 | 2,400 | 3,960 | 4,000 | 1.6 K to 4 K (+150.00 %) |
May 27 2011 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Buy | P | 1.63 | 100 | 163 | 1,600 | 1.5 K to 1.6 K (+6.67 %) |
May 27 2011 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Buy | P | 1.65 | 600 | 990 | 1,500 | 900 to 1.5 K (+66.67 %) |
May 27 2011 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Buy | P | 1.64 | 400 | 656 | 900 | 500 to 900 (+80.00 %) |
May 27 2011 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 1.60 | 500 | 798 | 14,752 | 14.3 K to 14.8 K (+3.51 %) |
May 27 2011 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 1.60 | 500 | 799 | 14,252 | 13.8 K to 14.3 K (+3.64 %) |
May 26 2011 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 1.73 | 552 | 954 | 13,752 | 13.2 K to 13.8 K (+4.18 %) |
May 26 2011 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 1.74 | 500 | 869 | 13,200 | 12.7 K to 13.2 K (+3.94 %) |
May 26 2011 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 1.72 | 500 | 860 | 12,700 | 12.2 K to 12.7 K (+4.10 %) |
May 26 2011 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 1.67 | 200 | 334 | 12,200 | 12 K to 12.2 K (+1.67 %) |
May 26 2011 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 1.69 | 800 | 1,354 | 12,000 | 11.2 K to 12 K (+7.14 %) |
Jan 13 2011 | NBY | NovaBay Pharmaceut ... | Cashion Charles | Director | Option Exercise | A | 1.67 | 39,749 | 66,381 | 39,749 | |
Jan 13 2011 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Option Exercise | A | 1.67 | 39,749 | 66,381 | 39,749 | |
Jan 05 2011 | NBY | NovaBay Pharmaceut ... | Maderis Gail J | Director | Option Exercise | A | 1.67 | 39,749 | 66,381 | 39,749 | |
Jan 05 2011 | NBY | NovaBay Pharmaceut ... | Dailley Anthony | Director | Option Exercise | A | 1.67 | 15,000 | 25,050 | 15,000 | |
Jan 05 2011 | NBY | NovaBay Pharmaceut ... | Tufts Robert R. | Director | Option Exercise | A | 1.67 | 27,375 | 45,716 | 27,375 | |
Jan 05 2011 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Option Exercise | A | 1.67 | 15,000 | 25,050 | 15,000 | |
Jan 05 2011 | NBY | NovaBay Pharmaceut ... | Wicks Tony D.S. | Director | Option Exercise | A | 1.67 | 15,000 | 25,050 | 15,000 | |
Nov 15 2010 | NBY | NovaBay Pharmaceut ... | WU ROY J | SVP Bus & Corp Deve ... | Option Exercise | A | 1.85 | 40,000 | 74,000 | 190,000 | |
Nov 15 2010 | NBY | NovaBay Pharmaceut ... | PAULSON THOMAS J | CFO | Option Exercise | A | 1.85 | 70,000 | 129,500 | 379,100 | |
Nov 15 2010 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Option Exercise | A | 1.85 | 130,000 | 240,500 | 448,200 | |
Nov 15 2010 | NBY | NovaBay Pharmaceut ... | Khosrovi Behzad | SVP Product Develop ... | Option Exercise | A | 1.85 | 40,000 | 74,000 | 364,200 | |
Nov 15 2010 | NBY | NovaBay Pharmaceut ... | Anderson Mark Brian | CSO | Option Exercise | A | 1.85 | 40,000 | 74,000 | 186,000 | |
Oct 08 2010 | NBY | NovaBay Pharmaceut ... | Maderis Gail J | Director | Option Exercise | A | 1.83 | 30,000 | 54,900 | 0 | |
Aug 25 2010 | NBY | NovaBay Pharmaceut ... | WU ROY J | SVP Bus & Corp Deve ... | Option Exercise | A | 1.95 | 37,500 | 73,125 | 150,000 | |
Aug 18 2010 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Sell | S | 1.83 | 15,000 | 27,450 | 12,137 | 27.1 K to 12.1 K (-55.28 %) |
Aug 18 2010 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Grant | A | 0.00 | 1,428 | 0 | 25,444 | 26.9 K to 25.4 K (-5.31 %) |
Jan 27 2010 | NBY | NovaBay Pharmaceut ... | Tufts Robert R. | Director | Option Exercise | M | 2.02 | 18,158 | 36,679 | 0 | |
Jan 27 2010 | NBY | NovaBay Pharmaceut ... | Tufts Robert R. | Director | Buy | M | 2.02 | 18,158 | 36,679 | 314,908 | 296.8 K to 314.9 K (+6.12 %) |
Jan 05 2010 | NBY | NovaBay Pharmaceut ... | Wicks Tony D.S. | Director | Option Exercise | A | 2.02 | 36,316 | 73,358 | 140,316 | |
Jan 05 2010 | NBY | NovaBay Pharmaceut ... | Tufts Robert R. | Director | Option Exercise | A | 2.02 | 25,658 | 51,829 | 74,158 | |
Jan 05 2010 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Option Exercise | A | 2.02 | 36,316 | 73,358 | 107,816 | |
Jan 05 2010 | NBY | NovaBay Pharmaceut ... | HIXSON HARRY F JR | Director | Option Exercise | A | 2.02 | 36,316 | 73,358 | 88,316 | |
Jan 05 2010 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Option Exercise | A | 2.02 | 15,000 | 30,300 | 155,000 | |
Jan 05 2010 | NBY | NovaBay Pharmaceut ... | Dailley Anthony | Director | Option Exercise | A | 2.02 | 30,987 | 62,594 | 91,987 | |
Jan 05 2010 | NBY | NovaBay Pharmaceut ... | Cashion Charles | Director | Option Exercise | A | 2.02 | 36,316 | 73,358 | 118,316 | |
Dec 14 2009 | NBY | NovaBay Pharmaceut ... | Tufts Robert R. | Director | Grant | A | 0.00 | 302 | 0 | 296,750 | 296.4 K to 296.8 K (+0.10 %) |
Dec 14 2009 | NBY | NovaBay Pharmaceut ... | Dailley Anthony | Director | Grant | A | 0.00 | 302 | 0 | 191,079 | 190.8 K to 191.1 K (+0.16 %) |